-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LAT-8881 in Radiculopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LAT-8881 in Radiculopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LAT-8881 in RadiculopathyDrug Details:LAT-8881 is under development for the treatment of migraine. The drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KP-1077 in Narcolepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KP-1077 in Narcolepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KP-1077 in Narcolepsy Drug Details: KP-1077 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KP-1077 in Idiopathic Hypersomnia (IH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KP-1077 in Idiopathic Hypersomnia (IH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KP-1077 in Idiopathic Hypersomnia (IH) Drug Details: KP-1077 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Emodepside in Ancylostomiasis (Hookworm Infections)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Emodepside in Ancylostomiasis (Hookworm Infections) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Emodepside in Ancylostomiasis (Hookworm Infections) Drug Details: Emodepside is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KP-879 in Substance (Drug) Abuse
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.KP-879 in Substance (Drug) Abuse Drug Details:KP-879 (prodrug of d-methylphenidate) is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – IK-930 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IK-930 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IK-930 in Non-Small Cell Lung Cancer Drug Details: IK-930 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IK-930 in Malignant Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IK-930 in Malignant Mesothelioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.IK-930 in Malignant Mesothelioma Drug Details:IK-930 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IK-930 in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IK-930 in Soft Tissue Sarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.IK-930 in Soft Tissue Sarcoma Drug Details:IK-930 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACD-101 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACD-101 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ACD-101 in Glioblastoma Multiforme (GBM) Drug Details:ACD-101 (131I-ACD-101) is under development for...